background image

Paid Clinical Trials Fargo

Discover 167 paid clinical trials in Fargo, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

VK2735 for Weight Management Phase 3

for
Weight Loss
Location: Fargo ND, Omaha NE, West Des Moines IA, Kansas City MO,
Sponsor: Viking Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07104500

Phase3, Recruiting
New

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Fargo ND, Minneapolis MN, Sioux Falls SD, Rochester MN,
Sponsor: Children's Oncology Group

Sex: All

Age: 365 - 30

Code: NCT03126916

Phase3, Recruiting

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for
Rectal Cancer
Location: Fargo ND, Bemidji MN, Bismarck ND, Winnipeg,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06205485

Phase3, Recruiting

Alcohol Related Impairment and Reinforcement: Pre to Post Roux en Y Gastric Bypass Surgery

for
Bariatric Surgery Candidate
Location: Fargo ND
Sponsor: Neuropsychiatric Research Institute, Fargo, North Dakota

Sex: All

Age: 21 - 65

Code: NCT02370732

Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: Fargo ND, Rolling Meadows IL, Peoria IL, Hinsdale IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Fargo ND, Minneapolis MN, Sioux Falls SD, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase3, Recruiting

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

for
Carcinoma, Non-Small-Cell Lung
Location: Fargo ND, Sioux Falls SD, Columbus OH, Lexington KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04165070

Phase1, Phase2, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Central Nervous System Germinoma,
Location: Fargo ND, Minneapolis MN, Sioux Falls SD, Rochester MN,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase2, Recruiting

REBYOTA™ Prospective Registry

for
Recurrence of Clostridium Difficile Infection
Location: Fargo ND, Omaha NE, Iowa City IA, Maywood IL,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05835219

Recruiting

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

for
Periprosthetic Joint Infections
Location: Fargo ND, Skokie IL, Ann Arbor MI, Indianapolis IN,
Sponsor: Elute, Inc.

Sex: All

Age: 22+

Code: NCT05361941

Recruiting